Clinical Trial Update: Increasing HAART-Induced Immune Restoration With Cyclosporine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclosporine to boost immune restoration in HIV patients receiving HAART; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED